QC
NVAX icon

Quent Capital’s Novavax NVAX Stock Holding History

Quent Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9
Closed -$114 – 1395
2024
Q3 		$114 Hold
9
– – ﹤0.01% 1338
2024
Q2 		$114 Hold
9
– – ﹤0.01% 1330
2024
Q1 		$43 Sell
9
-5
-36% -$23 ﹤0.01% 1345
2023
Q4 		$67 Buy
14
+5
+56% +$31 ﹤0.01% 1316
2023
Q3 		$65 Sell
9
-150
-94% -$1.2K ﹤0.01% 1304
2023
Q2 		$1.18K Hold
159
– – ﹤0.01% 1230
2023
Q1 		$1.1K Buy
159
+43
+37% +$396 ﹤0.01% 1236
2022
Q4 		$1.19K Buy
116
+107
+1,189% +$1.89K ﹤0.01% 1213
2022
Q3 		$0 Hold
9
– – ﹤0.01% 1260
2022
Q2 		$0 Hold
9
– – ﹤0.01% 1267
2022
Q1 		$1K Buy
+9
New +$803 ﹤0.01% 1210

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Quent Capital's NVAX Position: Q4 2024 in Review

Quent Capital sold out of Novavax (NVAX) in Q4 2024, closing a stake of 9 shares — an estimated $114 sold.

Quent Capital first reported a position in NVAX in Q1 2022 and held it in 11 quarters. The position peaked at $1.19K in Q4 2022. 234 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

  • Quent Capital reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
  • Quent Capital sold 9 Novavax shares in Q4 2024, an estimated $114.
  • Quent Capital first reported a position in Novavax in Q1 2022 and held it in 11 quarters.
  • Quent Capital's Novavax position peaked at $1.19K in Q4 2022.
  • 234 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Quent Capital's 13F filing for Q4 2024, filed 29 Jan 2025.